Lantheus Holdings Inc
NASDAQ:LNTH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
51.07
123.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Lantheus Holdings Inc
Lantheus Holdings Inc
Other Long-Term Assets
Lantheus Holdings Inc
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Other Long-Term Assets
$151.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
18%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Other Long-Term Assets
$164.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
37%
|
CAGR 10-Years
30%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Other Long-Term Assets
$263m
|
CAGR 3-Years
27%
|
CAGR 5-Years
23%
|
CAGR 10-Years
6%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Other Long-Term Assets
$121.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
36%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Other Long-Term Assets
$1.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
77%
|
CAGR 10-Years
52%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Other Long-Term Assets
$69.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
15%
|
|
Lantheus Holdings Inc
Glance View
Lantheus Holdings Inc. is a captivating player in the healthcare sector, primarily operating within the niche of diagnostic medical imaging. The company's core mission revolves around enhancing diagnosis and treatment pathways, thus playing an integral role in patient care. At the heart of Lantheus's operations are its innovative diagnostic and therapeutic products, including radiopharmaceuticals and contrast agents that physicians rely on to obtain detailed images of the body's organs and tissues. Through a combination of proprietary technologies and strategic partnerships, Lantheus delivers solutions that help medical professionals make more informed clinical decisions, ultimately aiming to improve patient outcomes. This business generates revenue by developing, manufacturing, and commercializing its products, which are utilized across hospitals, clinics, and research centers worldwide. By consistently investing in research and development, Lantheus ensures a competitive edge through a robust pipeline of next-generation imaging agents. Strategic alliances and collaborative ventures further fortify its market presence, allowing the company to expand its reach and integrate new advancements into its product offerings. This commitment to innovation and collaboration has not only cemented its reputation in the life sciences industry but also ensures a steady and growing stream of income from its well-regarded product lines.
See Also
What is Lantheus Holdings Inc's Other Long-Term Assets?
Other Long-Term Assets
151.5m
USD
Based on the financial report for Sep 30, 2024, Lantheus Holdings Inc's Other Long-Term Assets amounts to 151.5m USD.
What is Lantheus Holdings Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
18%
Over the last year, the Other Long-Term Assets growth was -7%. The average annual Other Long-Term Assets growth rates for Lantheus Holdings Inc have been 14% over the past three years , 7% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet